aflibercept
aflibercept is listed in the FDA National Drug Code directory with 13 NDC codes, marketed under brand names including ENZEEVU, EYLEA, EYLEA HD. Available dosage forms: injection, solution, injection.
Drug details
- Generic Name
- aflibercept
- Brand Names
- ENZEEVU, EYLEA, EYLEA HD
- Application Number
- BLA761382
- Sponsor
- Regeneron Pharmaceuticals, Inc
- NDC Codes
- 13
- Dosage Forms
- INJECTION, SOLUTION, INJECTION
- Routes
- INTRAVITREAL
- Active Ingredients
- AFLIBERCEPT, AFLIBERCEPT-YSZY
Indications and Usage
1 INDICATIONS AND USAGE EYLEA is indicated for the treatment of: EYLEA is a vascular endothelial growth factor (VEGF) inhibitor indicated for the treatment of patients with: Neovascular (Wet) Age-Related Macular Degeneration (AMD) ( 1.1 ) Macular Edema Following Retinal Vein Occlusion (RVO) ( 1.2 ) Diabetic Macular Edema (DME) ( 1.3 ) Diabetic Retinopathy (DR) ( 1.4 ) Retinopathy of Prematurity (ROP) ( 1.5 ) 1.1 Neovascular (Wet) Age-Related Macular Degeneration (AMD) 1.2 Macular Edema Following Retinal Vein Occlusion (RVO) 1.3 Diabetic Macular Edema (DME) 1.4 Diabetic Retinopathy (DR) 1.5 Retinopathy of Prematurity (ROP)